Mutations in ATP13A2 have been identified in a familiar form of Parkinson's disease [53] and more recently in NCLs [49], [54], [55] suggesting that metal transporters are important, yet relatively little explored in these diseases. This evidence concerns the gene ATP13A2 and Parkinson disease.